Clinical Trials Browser

Phase 3 × Melanoma × Antibodies, Monoclonal × Clear all

NCT00094653 2011-07-11

MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma

Phase 3 Completed

1,783 enrolled 29 charts

Melanoma, Neoplasm Metastasis, Skin Neoplasms